propranolol has been researched along with Endomyocardial Fibrosis in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol treatment, which can induce cardiac depression in the normal heart, actually prevented cardiac dilation and the depressed left ventricular function characteristic of older TG mice, and abolished premature mortality." | 1.30 | Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. ( Asai, K; Bishop, S; Geng, YJ; Homcy, CJ; Ishikawa, Y; Shannon, RP; Takagi, G; Vatner, DE; Vatner, SF; Wagner, TE; Yang, GP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bustinduy, AL | 1 |
| Luzinda, K | 1 |
| Mpoya, S | 1 |
| Gothard, P | 1 |
| Stone, N | 1 |
| Wright, S | 1 |
| Stothard, JR | 1 |
| Wang, Y | 1 |
| Pinto, JR | 1 |
| Solis, RS | 1 |
| Dweck, D | 1 |
| Liang, J | 1 |
| Diaz-Perez, Z | 1 |
| Ge, Y | 1 |
| Walker, JW | 1 |
| Potter, JD | 1 |
| Asai, K | 1 |
| Yang, GP | 1 |
| Geng, YJ | 1 |
| Takagi, G | 1 |
| Bishop, S | 1 |
| Ishikawa, Y | 1 |
| Shannon, RP | 1 |
| Wagner, TE | 1 |
| Vatner, DE | 1 |
| Homcy, CJ | 1 |
| Vatner, SF | 1 |
| Goodwin, JF | 1 |
1 review available for propranolol and Endomyocardial Fibrosis
| Article | Year |
|---|---|
The cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Adult; Amyloidosis; Angiography; Cardiac Output; Cardiomyopathies; Cate | 1974 |
3 other studies available for propranolol and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?
Topics: Animals; Anthelmintics; Child; Endomyocardial Fibrosis; Feces; Humans; Liver Diseases; Male; Praziqu | 2014 |
Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
Topics: Amino Acid Substitution; Animals; Anti-Arrhythmia Agents; Calcium; Cardiomyopathy, Hypertrophic, Fam | 2012 |
Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomyopathy, Dilated; Cy | 1999 |